Cargando…

The relationship between proton pump inhibitor use and serum magnesium concentration among hemodialysis patients: a cross-sectional study

BACKGROUND: Observational data suggest that serum magnesium (Mg) concentration is inversely related to vascular calcification and hyperparathyroidism among patients with end-stage renal disease (ESRD). In recent years, there have been several case reports of hypomagnesemia due to use of proton-pump...

Descripción completa

Detalles Bibliográficos
Autores principales:	Misra, Paraish S., Alam, Ahsan, Lipman, Mark L., Nessim, Sharon J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4535779/ https://www.ncbi.nlm.nih.gov/pubmed/26268579 http://dx.doi.org/10.1186/s12882-015-0139-9

Ejemplares similares

Proton Pump Inhibitor Use and Magnesium Concentrations in Hemodialysis Patients: A Cross-Sectional Study
por: Nakashima, Akio, et al.
Publicado: (2015)

Proton Pump Inhibitors and Serum Magnesium Levels in Patients With Torsades de Pointes
por: Lazzerini, Pietro E., et al.
Publicado: (2018)

Changes in serum magnesium concentration after use of a proton pump inhibitor in patients undergoing percutaneous coronary intervention
por: Park, Sang-Ho, et al.
Publicado: (2015)

Proton pump inhibitors with calcium acetate on serum phosphorus levels in hemodialysis patients
por: Cekiç, Deniz, et al.
Publicado: (2023)

Comment on “Estimating serum‐ionized magnesium concentration in hemodialysis patients”
por: Begos, Dennis G., et al.
Publicado: (2021)

PS212. Effects of Proton Pump Inhibitors (PPI) on the Serum Concentrations of Venlafaxine
por: Paulzen, Michael, et al.
Publicado: (2016)

Proton Pump Inhibitor Usage and the Risk of Mortality in Hemodialysis Patients
por: de Francisco, Angel L.M., et al.
Publicado: (2017)

Proton-Pump Inhibitors and Serum Concentrations of Uremic Toxins in Patients with Chronic Kidney Disease
por: El Chamieh, Carolla, et al.
Publicado: (2023)

Effect of proton pump inhibitors on sympathetic hyperinnervation in infarcted rats: Role of magnesium
por: Lee, Tsung-Ming, et al.
Publicado: (2018)

Increased Proton Pump Inhibitors−Induced Mortality Risk in Hemodialysis Patients
por: Sertorio, Jonas T., et al.
Publicado: (2018)

Effect of Proton Pump Inhibitors on the Serum Concentrations of the Selective Serotonin Reuptake Inhibitors Citalopram, Escitalopram, and Sertraline
por: Gjestad, Caroline, et al.
Publicado: (2015)

Effects of Proton Pump Inhibitors on Patient Survival in Patients Undergoing Maintenance Hemodialysis
por: Kang, Seok Hui, et al.
Publicado: (2023)

Monitoring of serum magnesium levels during long-term use of proton pump inhibitors in elderly japanese patients: is it really necessary or not?
por: Nakamura, Nobuhiko, et al.
Publicado: (2022)

The Association of Diuretics and Proton Pump Inhibitors With Chondrocalcinosis
por: Felson, David T., et al.
Publicado: (2021)

The relationship between proton pump inhibitors and renal disease
por: Morschel, Carine Franco, et al.
Publicado: (2018)

Proton Pumps: Molecular Mechanisms, Inhibitors and Activators of Proton Pumping
por: Siletsky, Sergey A.
Publicado: (2023)

Proton pump inhibitor as an independent factor of progression of abdominal aortic calcification in patients on maintenance hemodialysis
por: Okamoto, Teppei, et al.
Publicado: (2018)

Effects of proton pump inhibitors and electrolyte disturbances on arrhythmias
por: El-Charabaty, Elie, et al.
Publicado: (2013)

Helicobacter pylori and Serum Magnesium Level in Hemodialysis Patients
por: Nasri, Hamid
Publicado: (2014)

Serum Magnesium and Sudden Death in European Hemodialysis Patients
por: de Roij van Zuijdewijn, Camiel L. M., et al.
Publicado: (2015)

Diabetes Mellitus Modifies the Associations of Serum Magnesium Concentration With Arterial Calcification and Stiffness in Incident Hemodialysis Patients
por: Chen, Wei, et al.
Publicado: (2019)

Proton Pump Inhibitors and Gastritis
por: Suzuki, Masayuki, et al.
Publicado: (2008)

Proton pump inhibitors and gastroenteritis
por: Hassing, Robert-Jan, et al.
Publicado: (2016)

Deprescribing proton pump inhibitors
por: Teh, Kim Jun Kevin, et al.
Publicado: (2023)

Effects of Proton Pump Inhibitor Therapy, H. pylori Infection and Gastric Preneoplastic Pathology on Fasting Serum Gastrin Concentrations
por: Veysey-Smith, Reuben, et al.
Publicado: (2021)

Proton Pump Inhibitor Use, Hypergastrinemia, and Gastric Carcinoids—What Is the Relationship?
por: McCarthy, Denis M.
Publicado: (2020)

Ionized and total serum magnesium in hemodialysis: predictors and variability. A longitudinal cross-sectional study
por: Del Giorno, Rosaria, et al.
Publicado: (2017)

Magnesium alginate versus proton pump inhibitors for the treatment of laryngopharyngeal reflux: a non-inferiority randomized controlled trial
por: Pizzorni, Nicole, et al.
Publicado: (2022)

Assessment of the Proton Pump Inhibitor, Esomeprazole Magnesium Hydrate and Trihydrate, on Pathophysiological Markers of Preeclampsia in Preclinical Human Models of Disease
por: de Alwis, Natasha, et al.
Publicado: (2022)

Pharmacokinetics and Pharmacodynamics of the Proton Pump Inhibitors
por: Shin, Jai Moo, et al.
Publicado: (2013)

Proton pump inhibitors and hypomagnesemia monitoring
por: Lemon, Thomas I
Publicado: (2013)

Use and overuse of proton pump inhibitors
por: Staiano, Annamaria, et al.
Publicado: (2015)

Symptomatic hypomagnesemia and proton pump inhibitors
por: Tin, Sim Sai, et al.
Publicado: (2014)

Daily Magnesium Intake and Serum Magnesium Concentration among Japanese People
por: Akizawa, Yoriko, et al.
Publicado: (2008)

Relationship between serum total carbon dioxide concentration and bicarbonate concentration in patients undergoing hemodialysis
por: Hirai, Keiji, et al.
Publicado: (2020)

Massive Transfusion Increases Serum Magnesium Concentration
por: Malinowska, Justyna, et al.
Publicado: (2023)

Proton pump inhibitor use: systematic review of global trends and practices
por: Shanika, Lelwala Guruge Thushani, et al.
Publicado: (2023)

Risk of Pyogenic Liver Abscess in Proton Pump Inhibitor Users: New Inventory of Proton Pump Inhibitor Induced Complications?
por: Bang, Ki Bae
Publicado: (2021)

The association of low serum magnesium levels with frailty among hemodialysis patients
por: Hori, Mayuko, et al.
Publicado: (2023)

Management of laryngopharyngeal reflux with proton pump inhibitors
por: Reimer, Christina, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_a6p3nfvvqa3f879e682ohcboka